Shenglian Gan
- Endocrinology, Diabetes and Metabolism
- Molecular Biology
- Surgery
- Epidemiology
- Cardiology and Cardiovascular Medicine
- Co-authors
- Shijun GongYuhua ZhangYunfeng LiuQin LiuLiyin ZhangJianhua MaJuan ZhangXiaolin Dong
- Topics
- Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers)Cardiovascular Health and Disease Prevention (4 papers)Adipokines, Inflammation, and Metabolic Diseases (2 papers)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Shenglian Gan
10 papers receiving 145 citations
Peers
Comparison fields: 5 of 38
- Endocrinology, Diabetes and Metabolism 94
- Molecular Biology 54
- Surgery 25
- Epidemiology 18
- Cardiology and Cardiovascular Medicine 16
Countries citing papers authored by Shenglian Gan
This map shows the geographic impact of Shenglian Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglian Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglian Gan more than expected).
Fields of papers citing papers by Shenglian Gan
This network shows the impact of papers produced by Shenglian Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglian Gan. The network helps show where Shenglian Gan may publish in the future.
Co-authorship network of co-authors of Shenglian Gan
This figure shows the co-authorship network connecting the top 25 collaborators of Shenglian Gan. A scholar is included among the top collaborators of Shenglian Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglian Gan. Shenglian Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 4 | |
| 7 | 3 | |
| 8 | 11 | |
| 9 | 7 | |
| 10 | 4 | |
| 11 | 0 | |
| 12 | 5 | |
| 13 | 105 |
About Shenglian Gan
Shenglian Gan is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacy and Cardiology and Cardiovascular Medicine, having authored 13 papers that have together received 150 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Cardiovascular Health and Disease Prevention (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (94 citations), Nephrology (15 citations) and Clinical Biochemistry (13 citations). Shenglian Gan has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Shijun Gong, Yuhua Zhang, Yunfeng Liu, Qin Liu, Liyin Zhang, Jianhua Ma, Juan Zhang, Xiaolin Dong, Ting Sun and Wenli Zhang. Their work appears in journals such as Scientific Reports, Medicine and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.